About Single dose
Single dose is a Healthcare company based in Mumbai (India) founded in 2000 by Kiran Vithal Pai. Online medical resource platform for healthcare professionals. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity in India is Aski Technologies Private Limited (U72900MH2019PTC329130). Its competitors include Medikabazaar and Aknamed; 2 of its 2 listed competitors have raised funding.
Company details
Founded in 2000 and based in Mumbai, India, an online platform is operated for healthcare professionals. Software is developed to facilitate doctors connections to networks and interactions with the medical industry for resource access. Features are included for suppliers, market management, and professional networking within the healthcare sector. Operations focus on digital tools to support medical resource distribution and collaboration.
- Headquarters Mumbai, India
- Founders Kiran Vithal Pai
- SectorsHealthcare
- Email••••••••
- Website singledose.com
- Social LinkedIn Facebook
- Legal Name Aski Technologies Private Limited
- Date of Incorporation 08 Aug, 2019
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹52,201
FY 2025 · -99% YoY
- Net Loss-₹81,531
FY 2025 · -156% margin
- EBITDA-₹73,994
FY 2025 · -142% margin
- Latest Funding Round$135.7K (USD), Unspecified
Dec 2020
- Investors
Associated legal entities of Single dose
Single dose operates through Aski Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aski Technologies Private Limited CIN U72900MH2019PTC329130 | Active | 08 Aug 2019 | Mumbai, Maharashtra | ₹0.0 Cr | 2 | View details |
Funding Insights of Single dose
- Total Rounds 1
- Last Round Unspecified — $135,700
- First Round $135,700
(Dec 2020)
- Investors Count 1
All 1 funding rounds of Single dose with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $135,700 | Unspecified | – | PitchRight Ventures | – |
1 investors in total: 1 institutional.
Investors in Single dose
Single dose has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include PitchRight Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital firm investing in diverse sectors with a founder-first approach. | 2016 | pitchright.ventures | Mumbai, India |
Investor details for Single dose
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aski Technologies Private Limited (Single dose)
Aski Technologies Private Limited is the primary company behind Single dose. The board of Aski Technologies Private Limited currently have 2 directors; the longest-serving is Ashwini Kiran Pai, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashwini Kiran Pai DIN 08533551 | Director | 08 Aug 2019 | 7 yrs 3 mo | Aski Technologies Private Limited |
| Kiran Vithal Pai DIN 03111796 | Director | 16 Jun 2020 | 6 yrs 4 mo | Aski Technologies Private Limited |
People of Single dose
1 people are tracked at Single dose (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for Single dose
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Single dose
Figures of Aski Technologies Private Limited, the primary company behind Single dose, for FY 2025. Revenue was ₹52,201 (-99% year on year). Net loss was -₹81,531 (-156% margin). EBITDA was -₹73,994 (-142% margin). Revenue has grown at a compounded annual rate of -85% over three years.
- ₹52,201Revenue · FY 2025 · -99% YoY
- -₹81,531Net loss · -156% margin
- -₹73,994EBITDA · -142% margin
- ₹1 LakhPaid-up capital
- -85%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Aski Technologies Private Limited are on its company page.
Detailed financial statements for Single dose
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Single dose
2 dated milestones of Single dose across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Single dose is founded.
- Funding First funding round of $136K.
Competitors of Single dose
Single dose has 2 listed competitors in our database, 2 of them funded. They include Medikabazaar and Aknamed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medikabazaar.com | 2014 | Mumbai, India | $184.89M | 547 | Online marketplace for medical supplies, equipment, and devices catering to healthcare providers | |
| aknamed.com | 2018 | Gurugram, India | $21.85M | 246 | Cloud and AI-based material management software for hospitals is offered. |
Detailed competitors of Single dose
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Single dose
Websites that share an audience with Single dose (singledose.com).
Websites whose visitors overlap most with Single dose. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Single dose
Single dose was founded in 2000 and raised its 1st funding round 20 years after it was founded.
Single dose is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Single dose, Aski Technologies Private Limited, reported revenue of ₹52,201 for FY 2025, down 99% year on year.
Founded in 2000 and based in Mumbai, India, an online platform is operated for healthcare professionals. Software is developed to facilitate doctors connections to networks and interactions with the medical industry for resource access. Features are included for suppliers, market management, and professional networking within the healthcare sector. Operations focus on digital tools to support medical resource distribution and collaboration.
Single dose's top competitors include Medikabazaar and Aknamed.
Single dose has 1 investor. Key investors include PitchRight Ventures.
Single dose operates through Aski Technologies Private Limited.
The legal entities of Single dose currently have 2 directors, including Kiran Vithal Pai, Ashwini Kiran Pai.